Ad is loading...
MLYS
Price
$12.45
Change
+$0.58 (+4.89%)
Updated
Nov 22, 03:30 PM (EDT)
PLRX
Price
$12.95
Change
+$0.09 (+0.70%)
Updated
Nov 22, 03:33 PM (EDT)
102 days until earnings call
Ad is loading...

MLYS vs PLRX

Header iconMLYS vs PLRX Comparison
Open Charts MLYS vs PLRXBanner chart's image
Mineralys Therapeutics
Price$12.45
Change+$0.58 (+4.89%)
Volume$300
CapitalizationN/A
Pliant Therapeutics
Price$12.95
Change+$0.09 (+0.70%)
Volume$100
CapitalizationN/A
MLYS vs PLRX Comparison Chart
Loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
MLYS vs. PLRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLYS is a Sell and PLRX is a Hold.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (MLYS: $11.87 vs. PLRX: $12.85)
Brand notoriety: MLYS and PLRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLYS: 128% vs. PLRX: 151%
Market capitalization -- MLYS: $590.75M vs. PLRX: $781.97M
MLYS [@Biotechnology] is valued at $590.75M. PLRX’s [@Biotechnology] market capitalization is $781.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLYS’s FA Score shows that 0 FA rating(s) are green whilePLRX’s FA Score has 0 green FA rating(s).

  • MLYS’s FA Score: 0 green, 5 red.
  • PLRX’s FA Score: 0 green, 5 red.
According to our system of comparison, MLYS is a better buy in the long-term than PLRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLYS’s TA Score shows that 5 TA indicator(s) are bullish while PLRX’s TA Score has 4 bullish TA indicator(s).

  • MLYS’s TA Score: 5 bullish, 6 bearish.
  • PLRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both MLYS and PLRX are a bad buy in the short-term.

Price Growth

MLYS (@Biotechnology) experienced а -2.47% price change this week, while PLRX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.09%. For the same industry, the average monthly price growth was -5.02%, and the average quarterly price growth was +3.96%.

Reported Earning Dates

MLYS is expected to report earnings on Nov 11, 2024.

PLRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+2.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PLRX($782M) has a higher market cap than MLYS($591M). MLYS YTD gains are higher at: 38.023 vs. PLRX (-29.045). MLYS has higher annual earnings (EBITDA): -168.35M vs. PLRX (-197.04M). PLRX has more cash in the bank: 405M vs. MLYS (264M). MLYS (0) and PLRX (0) have equivalent revenues.
MLYSPLRXMLYS / PLRX
Capitalization591M782M76%
EBITDA-168.35M-197.04M85%
Gain YTD38.023-29.045-131%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M405M65%
Total DebtN/A60.2M-
TECHNICAL ANALYSIS
Technical Analysis
MLYSPLRX
RSI
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 3 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 17 days ago
89%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 5 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
MLYS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PLRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIPPX11.850.21
+1.80%
Principal MidCap Growth R4
UBVLX92.611.34
+1.47%
Undiscovered Managers Behavioral Val L
UNWPX1.530.01
+0.66%
US Global Investors World Prec Mnral
TCSHX14.530.06
+0.41%
Transamerica Multi-Asset Income C
SIDVX10.190.01
+0.10%
Hartford Schroders Intl Multi-Cp Val A

MLYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLYS has been loosely correlated with RXRX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MLYS jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLYS
1D Price
Change %
MLYS100%
-5.79%
RXRX - MLYS
40%
Loosely correlated
-4.80%
ADCT - MLYS
40%
Loosely correlated
-2.02%
PLRX - MLYS
40%
Loosely correlated
+0.94%
PRME - MLYS
40%
Loosely correlated
-0.67%
LYEL - MLYS
39%
Loosely correlated
-11.01%
More

PLRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLRX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PLRX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLRX
1D Price
Change %
PLRX100%
+0.94%
NTLA - PLRX
51%
Loosely correlated
+5.18%
RCKT - PLRX
51%
Loosely correlated
-1.92%
BEAM - PLRX
50%
Loosely correlated
-3.72%
ABSI - PLRX
49%
Loosely correlated
-4.85%
PRME - PLRX
48%
Loosely correlated
-0.67%
More